Giorgia Brambilla Pisoni awarded PhD
on March 10, 2016 Giorgia Brambilla Pisoni successfully defended her PhD thesis, which was presented at the ETH of Zurich, Switzerland. In her thesis, entitled “In vivo characterization of TMX1: TMX1 preferentially acts upon transmembrane polypeptides” Giorgia presented her contribution to the better characterization of poorly characterized members of the protein disulfide isomerase (PDI) superfamily […]
New paper by the Lanzavecchia Lab on Protective human-derived antibody against Ebola successfully isolated and characterized
on February 25, 2016 The Institute for Research in Biomedicine (IRB), affiliated to the Università della Svizzera italiana (USI), and Humabs BioMed SA, a Swiss antibody therapeutics company, have identified, isolated and characterized two Ebola virus neutralizing monoclonal antibodies from the blood of a survivor of an Ebola infection. The results were achieved through an […]
Sara Montagner awarded a Marie Heim-Vögtlin grant from the SNSF
on January 20, 2016 Sara Montagner was awarded a Marie Heim-Vögtlin (MHV) grant from the Swiss National Science Foundation for her project “Epigenetic regulation of mast cell differentiation and function”. Sara is about to complete her PhD thesis in the laboratory of Dr. Silvia Monticelli, and this fellowship will allow her to continue working on […]
New paper by the Grassi Lab
on January 13, 2016 Ectonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling
New paper by the Lanzavecchia Lab on New antibodies with an extra fragment overcome malaria parasite diversity, a study published in Nature
on December 23, 2015 A publication in the renowned scientific journal Nature describes a new groundbreaking mechanism that generates super-antibodies that can broadly target malaria parasites. The study was conducted at the Institute for Research in Biomedicine (IRB), affiliated to the Università della Svizzera Italiana (USI), in collaboration with the KEMRI-Wellcome Trust Research Programme in […]
New paper by Varani Lab
on December 4, 2015 Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein.
New publication from the laboratory of Federica Sallusto on serological memory published in the European Journal of Immunology
on December 1, 2015 The group led by Federica Sallusto at the IRB, institute affiliated to the Università della Svizzera italiana (USI), published an article in the European Journal of Immunology on the mechanisms regulating the generation of antibodies, proteins produced by B lymphocytes that play a major role in host protection against infection by […]
7th EADV Dermatological Meeting in Ticino – From the Bench to the Clinic
on October 23, 2015 We are delighted to announce that the 7th EADV Dermatological Meeting in Ticino organised by the Scientific Committee of the European Academy of Dermatology and Venereology (EADV) in close collaboration with the Società Ticinese di Dermatologia and the Institute for Research in Biomedicine, Università della Svizzera italiana, will take place Thursday, […]
MERS: Antibodies isolated at the IRB
on August 3, 2015 A group of international researchers, led by the Institute for Research in Biomedicine (IRB), has isolated an antibody against the Middle East Respiratory Syndrome (MERS), a potentially fatal disease of viral origin which was part of the headlines following the dozens of deaths recently registered in South Korea. This antibody could […]
Architectural design competition for the new headquarters of the IRB in Bellinzona – Project winner announced
on July 1, 2015 On April 15th, 2014, the Institute for Research in Biomedicine (affiliated to the USI) announced an architectural design competition for interdisciplinary teams, with a selective procedure, for the planning of the new headquarters of the IRB in the ex-military camp area (between via Francesco Chiesa and via del Bramantino). Basing itself […]
